![David Robinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Robinson
Corporate Officer/Principal at
OCULAR THERAPEUTIX, INC.
Net worth: 613 554 $ as of 30/05/2026
Profile
David W.
Robinson is the Global Chief Commercial Officer at Ocular Therapeutix, Inc. starting in 2026.
Former positions include Secretary, Co-CEO & General Counsel at Glowpoint, Inc. from 2009 to 2010; VP-Sales, Field Access & Reimbursement at Regeneron Pharmaceuticals, Inc.; Chief Marketing Officer-Global Ophthalmology at Merck & Co., Inc.; VP & GM-Immunology Business Unit at UCB, Inc.; and Vice President & General Counsel at Con Edison Communications from 2001 to 2006.
Education includes undergraduate degrees from Appalachian State University and the University of Pennsylvania, and a graduate degree from Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/06/2026 | 68,097 ( 0.03% ) | 613 554 $ | 30/05/2026 |
David Robinson active positions
| Companies | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 20/01/2026 |
Former positions of David Robinson
| Companies | Position | End |
|---|---|---|
Con Edison Communications
 Con Edison Communications Specialty TelecommunicationsCommunications Provides telecommunication services | General Counsel | 16/03/2006 |
| REGENERON PHARMACEUTICALS, INC. | Sales & Marketing | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
| OBLONG INC. | President | - |
Training of David Robinson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Glowpoint, Inc.
 Glowpoint, Inc. Specialty TelecommunicationsCommunications Provides cloud and managed visual communication solutions | Communications |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Con Edison Communications
Con Edison Communications Specialty TelecommunicationsCommunications Provides telecommunication services | Communications |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appalachian State University
 Appalachian State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
- Stock Market
- Insiders
- David Robinson
